An intelligent and advanced digital pathology solution requires artificial intelligence-based image analysis tools that empower pathologists to confidently and objectively assess whole tissue slide images.
The uPath PD-L1 (SP263) image analysis, NSCLC algorithm is an adjunctive computer-assisted tool that identifies PD-L1 positive and negative tumor cells within a pathologist-annotated viable tumor region in images of formalin-fixed, paraffin-embedded Non-small cell lung cancer (NSCLC) tissue.
Validated for use with the VENTANA PD-L1 (SP263) assay and Roche uPath enterprise software/ navify Digital Pathology.
Pathologist-trained image analysis algorithm quickly calculates PD-L1 tumor cell positivity.
Actionable assessment of slide images that are objective and reproducible.
The Roche Digital Pathology solution comprises high-performance hardware, software and uPath whole slide image analysis algorithms, and works in integrated harmony with the full Roche diagnostic portfolio for an end-to-end experience that enhances pathology workflows.
Registration Status
*CE-IVD marked. For Research Use Only in the US. Not for use in diagnostic procedures in the US.
Refer to the product-specific labeling for the regulatory status of the scanner and uPath. When Research Use Only products are used with IVD products, the integrated workflow will be for Research Use Only and cannot be used for diagnostic procedures.
